t(8;21)隐匿复杂变异易位-t(8;4;21)的遗传学及临床研究报道

李辉, 毛玥莹, 蒋显勇, 等. t(8;21)隐匿复杂变异易位-t(8;4;21)的遗传学及临床研究报道[J]. 临床血液学杂志, 2019, 32(1): 41-43,47. doi: 10.13201/j.issn.1004-2806.2019.01.011
引用本文: 李辉, 毛玥莹, 蒋显勇, 等. t(8;21)隐匿复杂变异易位-t(8;4;21)的遗传学及临床研究报道[J]. 临床血液学杂志, 2019, 32(1): 41-43,47. doi: 10.13201/j.issn.1004-2806.2019.01.011
LI Hui, MAO Yueying, JIANG Xianyong, et al. Genetic study of rare t(8;4;21)(q22;p15;q22):a cryptic and complex variant of t(8;21)[J]. J Clin Hematol, 2019, 32(1): 41-43,47. doi: 10.13201/j.issn.1004-2806.2019.01.011
Citation: LI Hui, MAO Yueying, JIANG Xianyong, et al. Genetic study of rare t(8;4;21)(q22;p15;q22):a cryptic and complex variant of t(8;21)[J]. J Clin Hematol, 2019, 32(1): 41-43,47. doi: 10.13201/j.issn.1004-2806.2019.01.011

t(8;21)隐匿复杂变异易位-t(8;4;21)的遗传学及临床研究报道

详细信息
    通讯作者: 李剑,E-mail:Lijian@pumch.cn
  • 中图分类号: R733.71

Genetic study of rare t(8;4;21)(q22;p15;q22):a cryptic and complex variant of t(8;21)

More Information
  • 目的:报道1例具有隐匿复杂变异易位-t(8;4;21)的M2型急性髓性白血病的遗传学及临床特征。方法:利用骨髓细胞短期培养法制备染色体标本;应用G显带技术进行核型分析;利用双色双融合荧光原位杂交检测RUNX1/RUNX1T1融合基因;采用实时荧光定量RT-PCR检测RUNX1/RUNX1T1融合基因转录本。结果:患者最初核型结果为46,XX,t(4;8)(p15;q22)[3]/45,sl,-X[17],但双色双融合荧光原位杂交证实存在RUNX1/RUNX1T1融合基因和变异易位,同时实时荧光定量RT-PCR检测到RUNX1/RUNX1T1融合基因转录本。因此核型结果最终修订为:46,XX,t(8;4;21)(q22;p15;q22)[3]/45,sl,-X[17],是一种t(8;21)隐匿复杂变异型易位。结论:联合双色双融合荧光原位杂交和实时荧光定量RT-PCR检测有助于鉴定出变异型t(8;21)易位。
  • 加载中
  • [1]

    Camerdinger U, Teigler-Schlegel A, Pils S, et al.Cryptic chromosomal aberrations leading to an AML1/ETO rearrgement are frequently caused by small insertions[J].Genes Chromosomes Cancer, 2003, 36:261-272.

    [2]

    Peterson LF, zhang DE.The 8;21translocation in leukemogenesis[J].Oncogene, 2004, 23:4255-4262.

    [3]

    Kuchenbauer F, Schnittger S, Look T, et al.Identification of additional cytogenetic and molecular genetic abnormalities in acute myeloid leukaemia with t (8;21)/AML1-ETO[J].Br J Haematol, 2006, 134:616-619.

    [4]

    Vieira L, Oliveira V, Ambrósio AP, et al.Translocation (8;17;15;21) (q22;q23;q15;q22) in acute myeloid leukemia (M2):a four-way variant of t (8;21)[J].Cancer Genet Cytogenet, 2001, 128:104-107.

    [5]

    Gabert J, Beillard E, van der Velden VH, et al.Standardization and quality control studies of'real-time'quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia-a Europe Against Cancer program[J].Leukemia, 2003, 17:2318-2357.

    [6]

    Beillard E, Pallisgaard N, van der Velden VH, et al.Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using'real-time'quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) -a Europe against cancer program[J].Leukemia, 2003, 17:2474-2486.

    [7]

    Vundinti BR, Kerketta L, Madkaikar M, et al.Three way translocation in a new variant of t (8;21) acute myeloid leukemia involving Xp22[J].Indian J Cancer, 2008, 45:30-32.

    [8]

    Ahmad F, Kokate P, Chheda P, et al.Molecular cytogenetic findings in a three-way novel variantof t (1;8;21) (p35;q22;q22):a unique relocationof the AML1/ETO fusion gene 1p35 in AML-M2[J].Cancer Genet Cytogenet, 2008, 180:153-157.

    [9]

    Kim H, Moon HW, Hur M, et al.Acute myeloid leukemia with a RUNX1-RUNX1T1t (1;21;8) (q21;q22;q22) novel variant:a case report and review of the literature[J].Acta Haematol, 2011, 125:237-241.

    [10]

    于力.血液系统恶性肿瘤精准诊疗现状与进展[J].临床血液学杂志, 2017, 30 (5):335-338.

    [11]

    冶秀鹏, 包慎, 魏玉萍, 等.以慢性粒单核细胞白血病样表现的急性髓细胞白血病1例并文献复习[J].临床血液学杂志, 2016, 29 (11):915-917.

  • 加载中
计量
  • 文章访问数:  487
  • PDF下载数:  77
  • 施引文献:  0
出版历程
收稿日期:  2018-10-10

目录